Related by context. All words. (Click for frequent words.) 74 Pemetrexed 74 Bevacizumab 73 Adalimumab 72 Capecitabine 72 Monotherapy 72 Etanercept 72 Golimumab 71 Decitabine 71 Gemcitabine 71 Previously Treated 71 Natalizumab 71 Peginterferon 70 Fludarabine 70 Epoetin Alfa 70 Combination Treatment 70 Lenalidomide 70 Interferon Beta 70 Paraplatin ® 70 Efficacious 70 Well Tolerated 70 Bortezomib 70 ACE Inhibitors 70 adalimumab Humira 70 Is Well Tolerated 70 Levofloxacin 70 Regimens 70 Darunavir 70 Newly Diagnosed Multiple Myeloma 69 Dasatinib 69 Fulvestrant 69 Pegylated Interferon 69 Prolongs Survival 69 Pegylated 69 JAK Inhibitor 69 Tiotropium 69 Pulmonary Arterial Hypertension 69 leukotriene receptor antagonist 69 Advanced Prostate Cancer 69 Darbepoetin Alfa 69 Renal Cell Carcinoma 69 Antitumor Activity 69 Allergic Rhinitis 69 Patients Treated 69 Unfractionated Heparin 69 Hepatitis C Genotype 69 Tipranavir 69 Disease Progression 69 Advanced Renal Cell 69 Adjuvant Therapy 69 Fixed Dose 68 Valsartan 68 Meets Primary Endpoint 68 Corticosteroids 68 Peginterferon Alfa 2a 68 Trastuzumab 68 Cutaneous T 68 Anthracycline 68 Investigational Drug 68 Resistant Hypertension 68 Rheumatoid Arthritis Patients 68 Methotrexate 68 Hepatitis C Patients 68 Infliximab 68 Tocilizumab 68 Soft Tissue Sarcoma 68 Demonstrated Significant 68 Receptor Antagonists 68 INVEGA ® 68 Phase III Trial 68 Neoadjuvant 68 Irinotecan 68 Atypical Antipsychotics 68 pharmacokinetic interactions 68 Bosutinib 68 Pfizer Sutent 68 Colorectal Cancer Patients 68 Posaconazole 68 Phase III Trials 68 mycophenolate mofetil 68 Patients Treated With 68 Traficet EN 68 Metastatic Colorectal Cancer 68 Mitoxantrone 68 Relapsing Remitting Multiple Sclerosis 68 Long Term Efficacy 68 paclitaxel Taxol 68 FASLODEX 67 Phase IIb Trial 67 Phase 2b Study 67 Chronic Hepatitis C 67 Advanced Melanoma 67 Oral Fingolimod 67 Benign Prostatic Hyperplasia 67 Immunosuppressant 67 ZOLINZA 67 Advanced Pancreatic Cancer 67 Investigational Agent 67 Shows Efficacy 67 Patients Receiving 67 Survival Benefit 67 Insulin Glargine 67 Plus Ribavirin 67 Hormone Refractory Prostate Cancer 67 Melphalan 67 CIMZIA ™ 67 Mg Uk 67 Recombinant Human 67 Cyclophosphamide 67 Treatment Regimen 67 Tyrosine Kinase Inhibitors 67 Erlotinib 67 Improves Survival 67 Mycophenolate Mofetil 67 Anticoagulant 67 Interferon beta 1a 67 Combination Therapy 67 Medoxomil 67 Non Responders 67 Complicated Skin 67 Fewer Side Effects 67 Cardiotoxicity 67 Montelukast 67 Methylnaltrexone 67 Immunosuppression 67 Corticosteroid 67 Bicalutamide 67 Overactive Bladder 67 Tumor Necrosis Factor 67 Certolizumab 67 erlotinib Tarceva ® 67 Ribavirin 67 Aflibercept 66 Fluorouracil 66 Acute Ischemic Stroke 66 Statistically Significant 66 Treated Patients 66 Previously Untreated 66 alfa 2a 66 PEGylated anti 66 Postmenopausal Osteoporosis 66 Remicade infliximab 66 Antipsychotic 66 ritonavir boosted 66 Myelodysplastic Syndromes 66 Oral Anticoagulant 66 Bisphosphonate 66 Lubiprostone 66 Investigational Compound 66 Vimpat R 66 adalimumab 66 etanercept Enbrel 66 Elderly Patients 66 Antiangiogenic 66 Pfizer Lyrica 66 Teriparatide 66 Low Dose 66 sertraline Zoloft 66 Dosed 66 docetaxel Taxotere ® 66 APTIVUS r 66 Advanced Colorectal Cancer 66 Fluticasone 66 Erectile Dysfunction Drug 66 Aliskiren 66 Immunomodulatory 66 Vidaza azacitidine 66 Doxil ® 66 Extended Release 66 Phase III Clinical Trial 66 Tacrolimus 66 Diuretic 66 GW# [003] 66 Relapsing Multiple Sclerosis 66 Phase 2a Trial 66 Carvedilol 66 Antidepressant Drug 66 Fluconazole 66 Aurora Kinase 66 antimuscarinic 66 DOXIL 66 rilonacept 66 Chemoradiation 66 HCV Protease Inhibitor 66 Study Evaluating 66 alefacept 66 tocilizumab 66 Rituximab 66 Phase IIb Clinical Trial 66 Phase 2b Clinical Trial 66 anti TNF 66 tigecycline 66 infliximab Remicade 66 R lenalidomide 66 Ofatumumab 66 ORENCIA ® 66 Laquinimod 66 Anti Tumor 66 Drug Candidate 66 Nilotinib 66 GnRH agonists 66 Epidermal Growth Factor Receptor 66 Improves Outcomes 66 Safinamide 66 Enzyme Replacement Therapy 66 Copegus ribavirin 66 Improved Survival 66 Navelbine ® 66 Pazopanib 66 biologic DMARD 66 Neulasta ® 66 Investigational Treatment 66 Metastatic Prostate Cancer 66 Significantly Reduced 66 Metronidazole 66 Bare Metal Stents 66 Eltrombopag 66 Diabetic Neuropathy 66 Ambrisentan 66 Taxotere ® 66 See CLINICAL PHARMACOLOGY 65 Alemtuzumab 65 Demonstrates Potential 65 Peg IFN 65 Versus Placebo 65 Novel Mechanism 65 Tolerability 65 AZILECT R 65 Sorafenib 65 Zileuton 65 Single Dose 65 Novel Oral 65 Sitagliptin 65 Eculizumab 65 Major Depressive Disorder 65 Adjunctive Therapy 65 Pegylated Liposomal Doxorubicin 65 Pharmacokinetic Study 65 Glufosfamide 65 Amlodipine 65 Anti VEGF 65 Glatiramer Acetate 65 Anticonvulsants 65 Interferon Alpha 65 TNF Tumor Necrosis Factor 65 Lamotrigine 65 Calcitonin 65 Androgen Deprivation Therapy 65 Protease Inhibitors 65 Platinol ® 65 Pioglitazone 65 Cethromycin 65 Disease Modifying 65 interferon therapy 65 Granulocyte Colony Stimulating Factor 65 Mg Usa 65 Dapagliflozin 65 STELARA TM 65 pegylated interferon alpha 65 Severe Sepsis 65 FIRMAGON 65 gefitinib Iressa 65 Infected Patients 65 Adjuvant Chemotherapy 65 Relapsed Multiple Myeloma 65 Lacosamide 65 Filgrastim 65 Gastrointestinal Stromal Tumors 65 Malignant Glioma 65 subcutaneously administered 65 Demonstrates Potent 65 SPRYCEL ® 65 Appears Safe 65 Danazol 65 Hypercholesterolemia 65 Relapsed Refractory 65 Beta Blocker 65 dasatinib Sprycel ® 65 sorafenib tablets 65 Salmeterol 65 Venlafaxine 65 Generic Versions 65 Treatment Experienced 65 Blinatumomab 65 Peginterferon Alfa 2b 65 efavirenz EFV 65 Heart Failure Patients 65 Roche Actemra 65 Anastrozole 65 Placebo Controlled Study 65 Betaferon R 65 ketoconazole 65 PEGylated Fab fragment 65 Ketorolac 65 C1 Inhibitor 65 Fibrates 65 Follicular Lymphoma 65 Atypical Antipsychotic 65 Chronic Lymphocytic Leukemia 65 Demonstrates Efficacy 65 Voreloxin 65 Cytotoxic 65 Faropenem 65 Tasigna nilotinib 65 Phase III Clinical Trials 65 Fondaparinux 65 Treatment Naive Patients 65 thalidomide Thalomid 65 Parnate 65 Nucleoside 65 HDAC Inhibitor 65 Teva Provides Update 65 Omalizumab 65 TNF alpha inhibitor 65 Transdermal Patch 65 Improve Survival 65 Epoetin 65 Protease Inhibitor 65 Ramelteon 65 Newly Diagnosed 65 Sapacitabine 65 Orally Active 65 Pooled Analysis 65 NMDA antagonist 65 Fungal Infections 65 Refractory Hodgkin Lymphoma 65 Anticancer Activity 65 Metastatic Renal Cell Carcinoma 65 Fabry Disease 65 APTIVUS 65 Hydroxyurea 65 Severe Asthma 65 5 Fluorouracil 65 Fingolimod 65 Bivalirudin 65 boosted protease inhibitor 65 Adjuvant Treatment 65 Gemzar ® 65 REYATAZ R 65 Telmisartan 65 pegylated interferons 65 Clinical Trial Results 65 Relapsed Refractory Multiple Myeloma 64 Rheumatoid Arthritis RA 64 Docetaxel 64 Double Blind Randomized 64 Myelodysplastic Syndrome MDS 64 INVEGA ® SUSTENNA ® 64 Romiplostim 64 aspirin clopidogrel 64 nucleoside analog 64 Signaling Pathway 64 Belimumab 64 PREZISTA r 64 intravenously administered 64 Leukemias 64 efalizumab 64 Neuroprotective Effects 64 imatinib Gleevec ® 64 paroxetine Paxil 64 Ecallantide 64 Beta Blockers 64 PEGASYS ® 64 Tekamlo 64 clomipramine 64 Paliperidone ER 64 Ticagrelor 64 Anti Tumor Activity 64 Novel Antibiotic 64 6R BH4 64 Talabostat 64 Boceprevir 64 Blood Pressure Lowering 64 Non Steroidal Anti Inflammatory 64 Generic Version 64 Phase 2a Clinical Trial 64 Risperidone 64 Noxafil 64 Exenatide 64 Imatinib 64 biologic therapy 64 CIMZIA TM 64 Ziprasidone 64 HER2 Positive Breast Cancer 64 TNF inhibitor 64 Azathioprine 64 Zoledronic acid 64 Subcutaneous 64 Schizophrenia Drug 64 PRISTIQ 64 Cholesterol Lowering Drug 64 Fludara ® 64 Maribavir 64 Ustekinumab 64 Ranolazine 64 Receptor Agonist 64 Pegasys ® 64 Pertuzumab 64 salmeterol fluticasone 64 Rivaroxaban 64 Randomized Phase 64 RAPTIVA 64 Alkeran 64 peginterferon alfa 64 Vfend 64 rufinamide 64 Gout Patients 64 incretin mimetic 64 INTEGRILIN R 64 Hsp# Inhibitor 64 LHRH agonists 64 Tyrosine Kinase Inhibitor 64 Raltegravir 64 Severe Chronic Pain 64 RAPAFLO 64 Zoledronic Acid 64 Camptosar ® 64 YONDELIS 64 Bosentan 64 dasatinib Sprycel 64 potentially hepatotoxic 64 Peginterferon alfa 2b 64 Azacitidine 64 INFERGEN 64 ARIXTRA R 64 Preclinical Data 64 PKC# 64 direct thrombin inhibitors 64 Multiple Myeloma Patients 64 Itraconazole 64 Adefovir 64 Pivotal Phase III 64 Antitumor 64 PREZISTA ritonavir 64 Progressive Multifocal Leukoencephalopathy 64 Non Inferiority 64 PEGylated interferon beta 1a 64 Enbrel Humira 64 Dalbavancin 64 Atomoxetine 64 Naive Patients 64 Fast Track Status 64 relapsed MM 64 Partial Onset Seizures 64 Elotuzumab 64 Universal Flu Vaccine 64 selective modulator 64 Tesamorelin 64 Castration Resistant Prostate Cancer 64 rFVIIa 64 administered subcutaneously 64 DMARDs 64 PEG interferon 64 icatibant 64 NDA Submission 64 Bipolar Mania 64 oral rivaroxaban 64 Antiviral Activity 64 Epratuzumab 64 Neuropathic Pain 64 6 mercaptopurine 64 II Clinical Trial 64 Chronic Myeloid Leukemia 64 Temsirolimus 64 Chronic Constipation 64 Abatacept 64 Degarelix 64 paliperidone palmitate 64 Solid Tumors 64 Fracture Risk 64 imatinib Gleevec 64 MAXALT 64 Cinacalcet 64 Tigecycline 64 Diabetic Patients 64 NICE Recommends 64 Avanafil 64 anti TNF alpha 64 Plaque Psoriasis 64 Cilostazol 64 Helicobacter pylori eradication 64 primidone 64 Pegloticase 64 Lung Cancer Drug 64 Ranibizumab 64 Lupus Nephritis 64 Generalized Anxiety Disorder 64 Monoclonal Antibody 64 diclofenac Voltaren 64 Levoleucovorin 64 systemic antifungal 64 GSK# [001] 64 Metastatic Melanoma 64 antineoplastic 64 Diabetic Foot Ulcer 64 Increlex R 64 Antifungal 64 factor TNF 64 CAELYX 64 Nebulized 64 azacitidine 64 Gout Drug 64 paroxetine sertraline 64 Placebo Controlled Trial 64 Septic Shock 64 Vandetanib 64 Soriatane 64 Tumor Response 64 zolmitriptan 64 Pharmacokinetics PK 64 Leucovorin 64 Randomized Double Blind 64 Elvitegravir 64 Combo Therapy 64 immunomodulatory therapy 64 glatiramer acetate 63 Carboplatin 63 Pivotal Phase 63 Renal Impairment 63 Renal Anemia 63 PEG INTRON 63 Oral Mucositis 63 LEUKINE 63 BARACLUDE ® 63 Enoxaparin 63 FDA Okays 63 Disease Modification 63 First Patient Dosed 63 MYCAMINE 63 TEMODAL 63 Adjunctive 63 Renal Cancer 63 Allogeneic 63 tyrosine kinase inhibitors TKIs 63 REYATAZ ® 63 decitabine 63 Interferon alpha 63 GlaxoSmithKline Requip 63 divalproex sodium 63 potassium sparing diuretics 63 Clinical Trial Evaluating 63 Osteoporosis Drug 63 Pregabalin 63 Stem Cell Transplants 63 raloxifene Evista 63 Novel Compound 63 RhuDex 63 meropenem 63 Replacement Therapy 63 doxazosin 63 Commonly Used 63 Chronic Hepatitis B 63 Pediatric Patients 63 anakinra 63 Hepatitis C Virus 63 Enlarged Prostate 63 Sertraline 63 Randomized Study 63 Budesonide 63 Epivir 63 administered concomitantly 63 Phase 2b Trial 63 Bucindolol 63 FOLFIRI 63 antiepileptics 63 Cyclooxygenase 2 63 Prophylaxis 63 Antipsychotics 63 pomalidomide 63 Isoniazid 63 Angioedema 63 Autologous Stem Cell Transplantation 63 Virologic 63 oral anticoagulants 63 nucleoside analogue 63 LATUDA 63 Renal Function 63 DMARDS 63 Unresectable 63 Hematological Malignancies 63 Oral Spray 63 dopamine partial agonist 63 lamivudine 3TC 63 cidofovir 63 Pegasys peginterferon alfa 2a 63 BANZEL 63 Sulfonylurea 63 Ozarelix 63 DORIBAX 63 Galantamine 63 DU #b 63 Anticancer Drugs 63 Cyclosporine 63 ACZ# 63 Commonly Prescribed 63 LHRH agonist 63 Serious Infections 63 Ixabepilone 63 prucalopride 63 XYOTAX TM 63 TNF antagonists 63 proteasome inhibitors 63 nucleoside analogues 63 Ciclesonide 63 Dose Escalation 63 pemetrexed Alimta 63 Statin Therapy 63 Angiogenic 63 Cytarabine 63 Interferon 63 interferon gamma 1b 63 Lung Cancer Patients 63 azathioprine 63 PROCRIT ® 63 dexamethasone Decadron 63 tipranavir 63 Reduced Risk 63 induce orthostatic hypotension 63 Orphan Designation 63 Progenitor Cells 63 phosphodiesterase type 5 63 Kidney Transplant Patients 63 Prophylactic Treatment 63 Pralatrexate 63 haloperidol Haldol 63 Lung Cancer Trial 63 Subgroup Analysis 63 nicardipine 63 Cardiovascular Events 63 Mylan Receives Approval 63 abacavir Ziagen 63 Hycamtin 63 Blood Pressure Drug 63 Inhalation Solution 63 Fludara 63 VAPRISOL 63 receptor tyrosine kinase inhibitor 63 Metastatic Pancreatic Cancer 63 eltrombopag 63 Sipuleucel T 63 Capsules CII 63 peginterferon 63 ibandronate 63 Initiate Clinical Trial 63 MULTAQ 63 briakinumab 63 Interferon Alfa 63 angiotensin converting enzyme inhibitors 63 Anticoagulants 63 recurrent glioblastoma multiforme 63 Torisel 63 pancreatic enzyme replacement 63 Gefitinib 63 calcineurin inhibitors 63 antithrombotics 63 Taxanes 63 Dyslipidemia 63 Antifungals 63 Zorbtive TM 63 Celebrex celecoxib 63 Inhaled Corticosteroids 63 rizatriptan 63 anticholinergics 63 ribavirin RBV 63 Nymox NX 63 Rilonacept 63 Sandostatin R 63 Monopril 63 Taxane 63 administered intranasally 63 Amiodarone 63 Telaprevir 63 Treatment Resistant 63 PegIntron 63 IRESSA 63 Breast Cancer Recurrence 63 Ischemic 63 topiramate Topamax 63 AstraZeneca Symbicort 63 tricyclic antidepressant 63 Radiofrequency Ablation 63 Bronchodilator 63 Roche Pegasys 63 follicular lymphomas 63 Telbivudine 63 antiplatelet agent 63 Acute Pancreatitis 63 Diabetic Nephropathy 63 Interferon alfa 63 Newly Diagnosed Patients 63 venlafaxine Effexor 63 Prostate Cancer Patients 63 lanreotide 63 trastuzumab Herceptin ® 63 Bipolar Depression 63 Ramipril 63 Orphan Status 63 octreotide acetate 63 TYKERB 63 ISENTRESS 63 vinca alkaloid 63 certolizumab 63 oral antidiabetic 63 Chemokine Receptor 63 Topotecan 63 cetuximab Erbitux R 63 Everolimus 63 somatostatin analogue 63 Elitek 63 EGFR TKI 63 Isotretinoin 63 Pirfenidone 63 Nitazoxanide 63 Present Preclinical Data 63 Pramipexole 63 Tarceva TM 63 acarbose 62 PRIALT 62 Lipid Lowering 62 Psoriasis Drug 62 NOXAFIL 62 abatacept Orencia 62 ADHD Medication 62 BARACLUDE R 62 immunomodulatory agents 62 Randomized Clinical Trial 62 IMiDs 62 systemic fungal infections 62 Telithromycin 62 Controlled Trial 62 proteasome inhibitor 62 SPRIX ® 62 Receptor Antagonist 62 Ritonavir 62 Tasimelteon 62 RISPERDAL ® CONSTA ® 62 Microplasmin 62 ziprasidone 62 selective phosphodiesterase 62 immunomodulator 62 HCV Genotype 62 Bupropion 62 TDF FTC 62 Antihistamine 62 uricase 62 Carbamazepine 62 mRCC 62 ORENCIA R 62 EGFr 62 AZT zidovudine Retrovir 62 Polymerase Inhibitor 62 PEGINTRON TM 62 Chronic Sinusitis 62 Herceptin trastuzumab 62 Gleevec resistant 62 xanthine oxidase inhibitor 62 insulin glulisine 62 Teriflunomide 62 erlotinib Tarceva 62 Clolar ® 62 Aripiprazole 62 Pafuramidine 62 PEG IFN 62 Riluzole 62 ribavirin therapy 62 Placebo Effect 62 canakinumab 62 Fibromyalgia Pain 62 Simulect 62 protease inhibitor PI 62 alpha interferons 62 HuMax CD4 62 Advagraf 62 Doxorubicin 62 mapatumumab 62 Mouse Model 62 Gastric Cancer 62 ZD# [001] 62 Kidney Function 62 ceftazidime 62 LY# [003] 62 vorinostat 62 Lansoprazole 62 Moxifloxacin 62 Vaginal Gel 62 bevacizumab Avastin 62 INTELENCE 62 sorafenib Nexavar 62 Fenofibrate 62 Sporanox 62 ARIXTRA 62 relapsing multiple sclerosis 62 topical gel formulation 62 Epoetin alfa 62 PegIFN RBV 62 trastuzumab Herceptin 62 Zolinza 62 Enzastaurin 62 Relapsed 62 Hydralazine 62 Prostacyclin 62 Allergic Asthma 62 Antipsychotic Drug 62 Topical Gel 62 Knee Osteoarthritis 62 Olmesartan 62 tipranavir ritonavir 62 INVANZ 62 Cimzia ® certolizumab pegol 62 Emerging Therapies 62 Cladribine 62 lansoprazole Prevacid 62 pyridostigmine 62 adult chronic ITP 62 Voltaren Gel 62 Valopicitabine 62 Pneumococcal Vaccine 62 Mirapexin 62 Significantly Improved 62 Diovan HCT 62 ACTEMRA TM 62 Epilepsy Drug 62 Paclitaxel Carboplatin 62 leukotriene receptor antagonists 62 Risedronate 62 CYT# potent vascular disrupting 62 Aptivus ® 62 Potent Antiviral Activity 62 KETEK 62 IV Busulfex 62 Oracea ® 62 MEK Inhibitor 62 panitumumab Vectibix 62 fulvestrant 62 ropinirole 62 Olanzapine 62 sitagliptin Januvia 62 pegfilgrastim 62 HoFH 62 conventional DMARDs 62 Blood Thinning 62 Transdermal Delivery 62 unfractionated heparin UFH 62 Sustained Release 62 Hepatitis B Vaccine 62 CYP#A# substrate 62 metastatic hormone refractory 62 zoledronate 62 Diabetic Neuropathic Pain 62 MAGE A3 ASCI 62 visilizumab 62 peripherally acting 62 glatiramer 62 antiandrogens 62 Myeloma Patients 62 Paliperidone Palmitate 62 Treating Chronic 62 long acting bronchodilator 62 Diabetic Macular Edema 62 Kepivance 62 Critically Ill Patients 62 IFN beta 62 denileukin diftitox 62 Dupuytren Contracture 62 nab paclitaxel 62 Study Showed 62 Neupogen ® 62 Romidepsin 62 Donepezil 62 cinacalcet 62 pegylated liposomal doxorubicin 62 Growth Hormone Deficiency 62 lacosamide 62 reuptake inhibitor 62 soluble tumor necrosis 62 Intracerebral Hemorrhage 62 MAOI 62 CCX# B 62 Paxil paroxetine 62 Kinase Inhibitor 62 Lilly Cymbalta 62 Hypertensive Patients 62 pegylated interferon alfa 2a 62 pegylated alpha interferon 62 Mipomersen 62 rosuvastatin Crestor 62 multitargeted 62 tricyclic antidepressants TCAs 62 mg Tablets 62 Celecoxib 62 Abacavir 62 Clostridium difficile Infection 62 nilotinib Tasigna 62 Efudex 62 SCH # 62 Temozolomide 62 prednisone prednisolone 62 Receives Positive Opinion 62 Community Acquired Pneumonia 62 KRN# 62 nizatidine 62 cholinesterase inhibitors 62 Zoloft sertraline 62 Intravesical 62 LOVENOX R 62 WelChol 62 interferon alfa 2b 62 Maleate 62 tricyclic 62 ZACTIMA 62 epoetin alfa 62 Pivotal Trial 62 TELINTRA 62 Androgel R 62 Anti Inflammatory Drugs 62 Tamibarotene 62 interferon IFN 62 COPEGUS R 62 Elesclomol 62 IFN α 62 Omacetaxine 62 Perifosine 62 adriamycin 62 Demonstrates Significant 62 Clofarabine 62 Daptomycin 62 Etravirine 62 Enalapril 62 Opioids 62 topical calcineurin inhibitors 62 REMICADE ® 62 clobazam 62 Zaleplon 62 tenofovir emtricitabine 62 Pharmacodynamics 62 Anticonvulsant 62 Treatment Reduces 62 Myelofibrosis 62 anti androgen 62 Tolvaptan 62 VEGF inhibitors 62 Cetuximab 62 AVELOX 62 uric acid lowering 62 Liver Failure 62 Squamous 62 Mesalamine 62 FDA Approvals 62 Amrubicin 62 Hormone Therapy 62 estramustine 62 Genentech Rituxan 62 Vaprisol 62 Glucocorticoid 62 Preclinical Models 62 R Saizen R 62 metaglidasen 62 nelfinavir 62 Taxol ® 62 relapsed multiple myeloma 62 Psychiatric Disorders 62 pyrazinamide 62 trabectedin 62 Sumatriptan 62 anti muscarinic 62 Benazepril 62 Lupus Drug 62 Submits NDA 62 Clinical Outcome 62 Prospective Randomized Trial 62 Lamivudine 62 paclitaxel Taxol R 62 Fixed Dose Combination 62 CANCIDAS 62 Female Sexual Arousal 62 Palonosetron 62 GRALISE 62 Exemestane 62 alkylating agent 62 gabapentin Neurontin 62 angiotensin receptor blocker ARB 62 Biosimilar 62 Parathyroid Hormone 62 Tezampanel 62 Dabigatran 62 Drug Shows Promise 62 PREZISTA rtv 62 atazanavir sulfate 62 antiplatelet medications 62 Acute Coronary Syndromes 62 Autoimmune Disorders 62 Skeletal Muscle 62 herpetic keratitis 62 monoamine oxidase inhibitors 62 dexpramipexole 62 lorazepam Ativan 62 Rheumatoid Arthritis Drug 62 lenalidomide Revlimid R 62 idraparinux 62 acitretin